REQUEST A DEMO
Total
USD $0.00
Search more companies

Roche D.O.O. Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Roche D.O.O. Beograd Profile Updated: September 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Roche D.O.O. Beograd is based in Serbia, with the head office in Belgrade. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on May 09, 2005. Roche D.O.O. Beograd currently employs 103 (2024) people. In its most recent financial highlights, the company reported a net sales revenue increase of 18.32% in 2024. Its’ total assets recorded a growth of 24.54%. In 2024, Roche D.O.O. Beograd’s net profit margin increased by 0.28%.

Headquarters
Vladimira Popovica 8A
Belgrade; Belgrade;

Contact Details: Purchase the Roche D.O.O. Beograd report to view the information.

Website: http://www.rochesrbija.rs

Basic Information
Total Employees:
Purchase the Roche D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Roche D.O.O. Beograd report to view the information.
Financial Auditors:
Purchase the Roche D.O.O. Beograd report to view the information.
Incorporation Date:
May 09, 2005
Key Executives
Purchase this report to view the information.
Acting General Director
Purchase this report to view the information.
Procurator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Roche D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
18.32%
Total operating revenue
18.31%
Operating profit (EBIT)
7.8%
EBITDA
10.62%
Net Profit (Loss) for the Period
33.78%
Total Assets
24.54%
Total Equity
10.44%
Operating Profit Margin (ROS)
-0.38%
Net Profit Margin
0.28%
Return on Equity (ROE)
1.65%
Debt/Equity
-1.12%
Quick Ratio
-0.1%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?